MRK Financial Facts
Research and development: 5.14BMaterials and production: 5.59B
See Full Income Statement
Noncontrolling Interests: 2.41B
Income taxes payable: 583.7M
See Full Balance Sheet
Earnings History for Merck & Co. Inc. (MRK)
|
Expand Research on MRK
| Next EPS Date | 7/26/13 *Est. | EPS Growth Rate | -14.1% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +4.3% | Revenue Growth Rate | -99.9% *Last Qtr. |
| Average % Move 1-Wk after EPS | -2.1% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/1/13  |
 |
Q113 | $0.85 | $0.79 | +$0.06 | $10.7M | $11.09M | N/A / N/A |  |
-2.1% | Details |
| 2/1/13 |
|
Q412 | $0.83 | $0.81 | +$0.02 | $11.7B | $11.46B | N/A / N/A | |
+6.3% | Details |
| 10/26/12 |
|
Q312 | $0.95 | $0.92 | +$0.03 | $11.5B | $11.6B | $0.94 / $11.71B | = | -0.7% | Details |
| 7/27/12 |
|
Q212 | $1.05 | $1.01 | +$0.04 | $12.2B | $12.16B | $1.02 / $12.18B | = | +6.1% | Details |
| 4/27/12 |
|
Q112 | $0.99 | $0.97 | +$0.02 | $11.73B | $11.82B | $0.99 / $11.79B | = | +19.5% | Details |
| 2/2/12 |
|
Q411 | $0.97 | $0.95 | +$0.02 | $12.29B | $12.53B | N/A / N/A | = | +19.1% | Details |
| 10/28/11 |
|
Q311 | $0.94 | $0.91 | +$0.03 | $12M | $11.61B | $0.93 / $11.5B | = | +34% | Details |
| 7/29/11 |
|
Q211 | $0.95 | $0.95 | $0.00 | $12.2B | $11.78M | N/A / N/A | = | +31.7% | Details |
